These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27796512)

  • 1. Gene Therapy in Heart Failure.
    Fargnoli AS; Katz MG; Bridges CR; Hajjar RJ
    Handb Exp Pharmacol; 2017; 243():395-421. PubMed ID: 27796512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for heart failure.
    Greenberg B
    Trends Cardiovasc Med; 2017 Apr; 27(3):216-222. PubMed ID: 28063800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function.
    Nagai T; Komuro I
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H501-12. PubMed ID: 22777420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery.
    Maurice JP; Hata JA; Shah AS; White DC; McDonald PH; Dolber PC; Wilson KH; Lefkowitz RJ; Glower DD; Koch WJ
    J Clin Invest; 1999 Jul; 104(1):21-9. PubMed ID: 10393695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for heart failure.
    Thompson RB; Rungwerth K; Koch WJ
    Ann Med; 2004; 36 Suppl 1():106-15. PubMed ID: 15176432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure gene therapy: the path to clinical practice.
    Pleger ST; Brinks H; Ritterhoff J; Raake P; Koch WJ; Katus HA; Most P
    Circ Res; 2013 Aug; 113(6):792-809. PubMed ID: 23989720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for gene transfer for clinical heart failure.
    Tang T; Gao MH; Hammond HK
    Gene Ther; 2012 Jun; 19(6):606-12. PubMed ID: 22534469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted gene therapy for the treatment of cardiac dysfunction.
    Askari AT; Penn MS
    Semin Thorac Cardiovasc Surg; 2002 Apr; 14(2):167-77. PubMed ID: 11988956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hopes for gene therapy for cardiac failure].
    Prunier F; Hajjar RJ
    Arch Mal Coeur Vaiss; 2006 Jan; 99(1):41-7. PubMed ID: 16479888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gene therapy in chronic heart failure--hopes and fears].
    Kaletha K; Chodorowski Z; Anand JS; Szydłowska M; Waldman W; Rybakowska I
    Przegl Lek; 2001; 58(4):229-31. PubMed ID: 11450341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent findings into the potential of gene therapy to reverse heart failure.
    Pleger ST; Most P; Koch WJ
    Expert Opin Biol Ther; 2007 Dec; 7(12):1781-4. PubMed ID: 18034643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous approaches for efficient cardiac gene delivery.
    Ishikawa K; Aguero J; Naim C; Fish K; Hajjar RJ
    J Cardiovasc Transl Res; 2013 Aug; 6(4):649-59. PubMed ID: 23749638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic manipulation of beta-adrenergic signalling in heart failure.
    Davidson MJ; Koch WJ
    Acta Physiol Scand; 2001 Sep; 173(1):145-50. PubMed ID: 11678737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal.
    Swain JD; Katz MG; White JD; Thesier DM; Henderson A; Stedman HH; Bridges CR
    Methods Mol Biol; 2011; 709():331-54. PubMed ID: 21194039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy targets in heart failure: the path to translation.
    Raake PW; Tscheschner H; Reinkober J; Ritterhoff J; Katus HA; Koch WJ; Most P
    Clin Pharmacol Ther; 2011 Oct; 90(4):542-53. PubMed ID: 21866097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure.
    Dieterle T; Meyer M; Gu Y; Belke DD; Swanson E; Iwatate M; Hollander J; Peterson KL; Ross J; Dillmann WH
    Cardiovasc Res; 2005 Sep; 67(4):678-88. PubMed ID: 15927173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer of beta-adrenergic signaling components for heart failure.
    Koch WJ
    J Card Fail; 2002 Dec; 8(6 Suppl):S526-31. PubMed ID: 12555169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium.
    Scimia MC; Cannavo A; Koch WJ
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):999-1013. PubMed ID: 23984926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.